Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Co-trimoxazole-induced hyperkalemia in hospitalized adults
NL-OMON21992Not yet recruiting
- Sponsor
- Canisius-Wilhelmina Hospital
- Start
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of trimethoprim + sulfamethoxazole and ceftriaxone in bacterial disease, sponsored by Canisius-Wilhelmina Hospital. Primary endpoint: Average serum potassium surge. Planned start Nov 2018; status: not yet recruiting.
02
Drugs
trimethoprim + sulfamethoxazoleceftriaxone
03
Conditions
bacterial disease
Beyond the preview
Go deeper on NL-OMON21992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21992.